Immuneering Corp

Nasdaq:IMRX

Pharmaceutical Preparations·CAMBRIDGE, MA

CEO

Zeskind Benjamin J.

Financials

19 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	3/6/26	→
10-Q	Q3 2025	9/30/25	11/12/25	→
10-Q	Q2 2025	6/30/25	8/13/25	→
10-Q	Q1 2025	3/31/25	5/5/25	→
10-K	FY 2024	12/31/24	3/20/25	→
10-Q	Q3 2024	9/30/24	11/13/24	→
↓

Earnings Releases (8-K)

19 shown

Filed	Period
3/6/26	Q1 FY2026	→
11/12/25	Q4 FY2025	→
8/13/25	Q3 FY2025	→
5/5/25	Q2 FY2025	→
3/20/25	Q1 FY2025	→
11/13/24	Q4 FY2024	→
↓

News (8-K)

23 shown

Filed	Type	Description
1/7/26	Other	Other Events	→
9/25/25	Agreement	Entry into a Material Definitive Agreement	→
9/24/25	Agreement	Entry into a Material Definitive Agreement	→
8/25/25	Agreement	Entry into a Material Definitive Agreement	→
6/17/25	Other	Other Events	→
6/16/25	Vote	Submission of Matters to a Vote of Security Holders	→
↓

Prospectuses & Registrations

19 shown

Filed	Form	Description
9/25/25	424B5	424B5	→
9/25/25	FWP	FWP	→
9/24/25	FWP	FWP	→
9/24/25	424B5	424B5	→
9/8/25	424B3	424B3	→
9/3/25	S-3	S-3	→
↓

Filing History(300 filings)

TypeDateAccessionPeriodSize

10-K

Mar 6, 2026

0001790340-26-00004210-K

Dec 31, 2025

14.4 MB

8-K

Mar 6, 2026

0001790340-26-0000408-K

Mar 6, 2026

297.5 KB

Feb 5, 2026

0001790340-26-000034FORM 4

Feb 3, 2026

5.3 KB

Feb 5, 2026

0001790340-26-000032FORM 4

Feb 3, 2026

5.3 KB

Feb 5, 2026

0001790340-26-000030FORM 4

Feb 3, 2026

5.3 KB

Feb 5, 2026

0001790340-26-000028FORM 4

Feb 3, 2026

5.3 KB

Feb 5, 2026

0001790340-26-000026FORM 4

Feb 3, 2026

5.3 KB

Feb 5, 2026

0001790340-26-000024FORM 4

Feb 3, 2026

5.3 KB

Feb 5, 2026

0001790340-26-000022FORM 4

Feb 3, 2026

5.3 KB

SCHEDULE 13G/A

Jan 22, 2026

0001790340-26-000020

—

7.0 KB

Jan 21, 2026

0001790340-26-000016FORM 4

Jan 16, 2026

4.5 KB

Jan 20, 2026

0001790340-26-000014FORM 4

Jan 15, 2026

4.7 KB

Jan 16, 2026

0001790340-26-000012FORM 4

Jan 15, 2026

4.9 KB

SCHEDULE 13G/A

Jan 15, 2026

0000902664-26-000247

—

12.1 KB

Jan 15, 2026

0001790340-26-000010FORM 4

Jan 13, 2026

4.4 KB

Jan 14, 2026

0001790340-26-000008FORM 4

Jan 12, 2026

7.0 KB

8-K

Jan 7, 2026

0001790340-26-0000068-K

Jan 7, 2026

150.3 KB

Jan 2, 2026

0001790340-26-000004FORM 4

Jan 1, 2026

5.8 KB

Jan 2, 2026

0001790340-26-000002FORM 4

Jan 1, 2026

5.8 KB

10-Q

Nov 12, 2025

0001790340-25-00013510-Q

Sep 30, 2025

6.3 MB

8-K

Nov 12, 2025

0001790340-25-0001338-K

Nov 12, 2025

266.2 KB

SCHEDULE 13G

Oct 21, 2025

0000902664-25-004478

—

16.8 KB

SCHEDULE 13G

Oct 7, 2025

0000315066-25-002312

—

11.2 KB

Oct 7, 2025

0001790340-25-000127FORM 4

Oct 3, 2025

6.6 KB

SCHEDULE 13G

Oct 3, 2025

0001104659-25-096664

—

7.5 KB

25 filings shown

Filed	Form	Description
4/21/25	DEFA14A	DEFA14A	→
4/21/25	DEF 14A	DEF 14A	→
4/23/24	DEFA14A	DEFA14A	→
4/23/24	DEF 14A	DEF 14A	→
5/1/23	DEFA14A	DEFA14A	→
5/1/23	DEF 14A	DEF 14A	→
↓

Immuneering Corp

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(300 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/5/26	4	4	→
2/5/26	4	4	→
2/5/26	4	4	→
2/5/26	4	4	→
2/5/26	4	4	→
2/5/26	4	4	→
↓

Filed	Form	Description
1/22/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/15/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
10/21/25	SCHEDULE 13G	SCHEDULE 13G	→
10/7/25	SCHEDULE 13G	SCHEDULE 13G	→
10/3/25	SCHEDULE 13G	SCHEDULE 13G	→
9/23/25	144	144	→
↓